ASKA Pharmaceutical Holdings Co Ltd 2021 Annual Report
Company: ASKA Pharmaceutical Holdings Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2021
Type: Annual Report
Pages: 13
The report describes the company's transition to a holding company structure in April 2021 and its ambition to become a total healthcare company. It sets out the Medium-Term Management Plan 2025, centered on specialty, ability to create and social contribution. The report also introduces a Group ESG Committee tasked with formulating ESG strategies, assessing activity plans and identifying material issues.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.